343 related articles for article (PubMed ID: 25944379)
21. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
Nabrinsky E; Danilov AV; Koller PB
Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515
[TBL] [Abstract][Full Text] [Related]
22. Therapies for mantle cell lymphoma: current challenges and a brighter future.
Skarbnik AP; Smith MR
Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
[TBL] [Abstract][Full Text] [Related]
23. Optimal management of mantle cell lymphoma in the primary setting.
Tang C; Kuruvilla J
Expert Rev Hematol; 2019 Sep; 12(9):715-721. PubMed ID: 31268728
[No Abstract] [Full Text] [Related]
24. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
25. Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered Questions.
Diamond B; Kumar A
Hematol Oncol Clin North Am; 2019 Aug; 33(4):613-626. PubMed ID: 31229158
[TBL] [Abstract][Full Text] [Related]
26. [Current treatment strategy in mantle cell lymphoma].
Ogura M
Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
[TBL] [Abstract][Full Text] [Related]
27. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
28. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
Nazeef M; Kahl BS
Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
[TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma: are current therapies changing the course of disease?
Geisler C
Curr Oncol Rep; 2009 Sep; 11(5):371-7. PubMed ID: 19679012
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling and management of mantle cell lymphoma.
Ruan J
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):30-40. PubMed ID: 31808882
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma: state-of-the-art management and future perspective.
Weigert O; Unterhalt M; Hiddemann W; Dreyling M
Leuk Lymphoma; 2009 Dec; 50(12):1937-50. PubMed ID: 19863180
[TBL] [Abstract][Full Text] [Related]
32. Unmet needs in the treatment of mantle cell lymphoma.
Rosen ST; Link BK; Fowler NH
Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
[TBL] [Abstract][Full Text] [Related]
33. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
34. Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L; King N; Lechowicz MJ; Lonial S; Sinha R; Flowers CR
Leuk Lymphoma; 2015 Feb; 56(2):383-9. PubMed ID: 24828864
[TBL] [Abstract][Full Text] [Related]
35. Emerging therapies in mantle cell lymphoma.
Hanel W; Epperla N
J Hematol Oncol; 2020 Jun; 13(1):79. PubMed ID: 32552760
[TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
[TBL] [Abstract][Full Text] [Related]
37. Results from the Belgian mantle cell lymphoma registry.
Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
[TBL] [Abstract][Full Text] [Related]
38. Treatment of mantle cell lymphoma: current approach and future directions.
Brody J; Advani R
Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
[TBL] [Abstract][Full Text] [Related]
39. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
Avivi I; Goy A
Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
[TBL] [Abstract][Full Text] [Related]
40. Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.
Cohen JB; Zain JM; Kahl BS
Am Soc Clin Oncol Educ Book; 2017; 37():512-525. PubMed ID: 28561694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
